An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04731675

Recruitment Status : Not yet recruiting

First Posted : February 1, 2021

Last Update Posted : February 1, 2021

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

AmMax Bio, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Not yet recruiting
Estimated Primary Completion Date :	May 2021
Estimated Study Completion Date :	August 2021

To Top